Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is UnitedHealth Group (UNH) a Buy Heading into Q2 Earnings Announcement?
Renowned health benefits provider UnitedHealth Group (UNH - Free Report) is set to report quarterly results Friday before the opening bell. UnitedHealth Group, a Zacks Rank #3 (Hold), has a robust history of exceeding earnings estimates. But as stocks have been volatile lately, is this market leader a buy heading into the Q2 earnings announcement?
Shares of UNH are up 1.37% this year, widely outperforming the major indices. Analysts are expecting the company to post Q2 EPS of $5.24 per share, which would translate to 11.49% growth versus the same quarter last year.
UnitedHealth Group has surpassed earnings estimates in every quarter for the past five years running. This long string of success suggests another earnings beat may be in store for investors. UNH has delivered a trailing four-quarter average earnings beat of 3.73%.
UNH is part of the Zacks Medical – HMOs industry, which ranks in the top 26% out of approximately 250 industry groups. The company pays a $6.60 (1.32%) annual dividend. UNH stock has really held up well this year while the market has corrected, and investors would be wise to pay attention as the company announces its latest results.